J Stroke Cerebrovasc Dis . Successful Endovascular Therapy in COVID-19 Associated Pediatric Ischemic Stroke

[tetano]

J Stroke Cerebrovasc Dis


. 2021 Oct 5;30(12):106152.
doi: 10.1016/j.jstrokecerebrovasdis.2021.106152. Online ahead of print.
Successful Endovascular Therapy in COVID-19 Associated Pediatric Ischemic Stroke


Dinesh V Jillella ¹ , Bryan Philbrook ² , Elissa Ortolani ³ , Jonathan A Grossberg ⁴ , Tristan Stani ⁵ , Owen Samuels ⁶ , Cederic Pimentel ⁷ , Amy Harrison ⁸ , Ashok R Polu ⁹ , Benjamin I Siegel ¹⁰ , Ian McCullough ¹¹ , Michael Cawley ¹² , Fadi Nahab ¹³



Affiliations

• PMID: 34649038
• DOI: 10.1016/j.jstrokecerebrovasdis.2021.106152

Abstract

Cerebrovascular diseases attributed to coronavirus disease 2019 (COVID-19) are uncommon but can result in devastating outcomes. Pediatric acute ischemic strokes are themselves rare and with very few large vessel occlusion related acute ischemic strokes attributed to COVID-19 described in the literature as of date. COVID-19 pandemic has contributed to acute stroke care delays across the world and with pediatric endovascular therapy still in its infancy, it poses a great challenge in facilitating good outcomes in children presenting with acute ischemic strokes in the setting of COVID-19. We present a pediatric patient who underwent endovascular therapy for an internal carotid artery occlusion related acute ischemic stroke in the setting of active COVID-19 and had an excellent outcome thanks to a streamlined stroke pathway involving the vascular neurology, neuro-interventional, neurocritical care, and anesthesiology teams.

Keywords: COVID-19; COVID-19 in children; Endovascular therapy; Hypercoagulable state; Pediatric stroke; Stroke in children; Stroke therapy.